Tag Archives: patent

Big time losers and the reasons why (NVS, JDAS, AKAM)

Posted on January 13, 2012 by Cameron White

In this report: Novartis (NYSE:NVS), JDA Software (NASDAQ:JDAS) and Akamai Technologies (NASDAQ:AKAM).

Novartis (NYSE:NVS) shares have dropped 1.7 percent so far today after the company announced that it will cut 1,960 jobs in the U.S. this year in order to …

Posted in Latest Headlines, Reports | Tagged AKAM, Akamai Technologies, analyst, Buy, company, DA Davidson, downgrade, earnings, firm, forecasted, JDA Software, JDAS, NASDAQ, NASDAQ:AKAM, NASDAQ:JDAS, Novartis, NVS, NYSE:NVS, patent, price target, profit, quarter, rating, report, restructuring, results, revenue, stock | Comments Off

Kodak sinks on bankruptcy financing reports

Posted on January 13, 2012 by Cameron White

Eastman Kodak (NYSE:EK) is trading over 22 percent lower today after it was reported that the struggling photography pioneer is in talks with Citigroup to get financing it would need if it filed for bankruptcy protection. Bloomberg news was the …

Posted in Main Post, Technology | Tagged Apple, bankruptcy, bid, bloomberg, Chapter 11, Citigroup, Eastman Kodak, EK, HTC, infringement, lawsuits, NYSE, NYSE:EK, patent, portfolio, protection, Research in Motion, trading | Comments Off

Thursday’s big time losers and the reasons why (EK, CWTR, OCR)

Posted on January 12, 2012 by Martin Timble

In this report: Eastman Kodak (NYSE:EK), Coldwater Creek (NASDAQ:CWTR) and Omnicare (NYSE:OCR).

Eastman Kodak (NYSE:EK) volatile shares tanked by more than 18 percent today after seeing 2 days of rallying after the company announced that it had filed a patent …

Posted in Latest Headlines, Reports | Tagged AAPL, acquisition, Analysts, Apple, Coldwater Creek, company, CWTR, deal, Eastman Kodak, EK, expects, Federal Trade Commision, HTC, infringement, NASDAQ, NASDAQ:AAPL, NASDAQ:CWTR, NYSE, NYSE:EK, NYSE:OCR, OCR, OmniCare, outlook, patent, PharMerica, quarter, retailer, RIM, shares, speculation, suits | Comments Off

What the fuss Lululemon, WebMD Health and Valeant Pharmaceutical?

Posted on January 10, 2012 by Josie Middleton

In this report: Lululemon (NASDAQ:LULU), WebMD Health Corp. (NASDAQ:WBMD) and Valeant Pharmaceutical International (NYSE:VRX).

Lululemon (NASDAQ:LULU) shares have soared by more than 15 percent today after the company raised its outlook for the fourth quarter due to better than expected …

Posted in Latest Headlines, Reports | Tagged analyst, CEO, company, earnings, firm, guidance, LULU, Lululemon, NASDAQ, NASDAQ:LULU, NASDAQ:WBMD, NYSE, NYSE:VRX, outlook, patent, products, quarter, rating, revenue, shares, upgrade, Valeant Pharmaceutical International, Wayne Gattinella, WebMD Health Corp. | Comments Off

What the fuss TiVo, Eastman Kodak and NetApp?

Posted on January 4, 2012 by Martin Timble

In this report: TiVo (NASDAQ:TIVO), Eastman Kodak (NYSE:EK) and NetApp (NASDAQ:NTAP).

TiVo (NASDAQ:TIVO) shares rallied by more than 10 percent on Wednesday after the company announced that it has reached a patent settlement with AT&T in which AT&T will pay …

Posted in Latest Headlines, Reports | Tagged Analysts, AT&T, bankruptcy, CEO, Chapter 11, company, Credit Suisse, digital, downgrade, Eastman Kodak, EK, filing, NASDAQ, NASDAQ:NTAP, NASDAQ:TIVO, NetApp, NTAP, NYSE, NYSE:EK, patent, pay, portfolio, protection, reported, rumor, settlement, shares, speculation, TiVo, Tom Rogers, wall street journal | Comments Off

What’s up MoSys, Frontier Communications and Tegal Corp.?

Posted on December 30, 2011 by Josie Middleton

In this report: MoSys Inc. (NASDAQ:MOSY), Frontier Communications Company (NYSE:FTR) and Tegal Corporation (NASDAQ:TGAL).

MoSys Inc. (NASDAQ:MOSY) shares jumped over 43 percent higher today after it was announced that company stated that they have entered into a patent purchase agreement …

Posted in Latest Headlines, Main Post, Reports | Tagged agreement, Analysts, company, coverage, firm, Frontier Communications Company, FTR, MOSY, MoSys Inc., Nanolayer, NASDAQ, NASDAQ:MOSY, NASDAQ:TGAL, NYSE, NYSE:FTR, patent, Piper Jaffray, purchase, rating, shares, subsidiary, technology, Tegal corporation, Tessera Technologies, TGAL | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.